RIMKA PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RIMKA PHARMA
Largest movements
- Receivables within one year +€331,347
up €331,347 (+342%), from €96,972 to €428,319
- Cash -€172,799
down €172,799 (-99.1%), from €174,286 to €1,487
mainly Receivables within one year (-€331,347) and Debts after one year (-€37,443)
- Tangible fixed assets -€20,062
down €20,062 (-3.2%), from €634,456 to €614,394
- Other debts +€177,219
up €177,219 (+42.1%), from €421,173 to €598,393
- Debts after one year -€37,443
down €37,443 (-28.6%), from €130,794 to €93,351
- Financial income +€12,818
up €12,818 (+6,691%), from €192 to €13,009
- Gross operating margin +€4,878
up €4,878 (+15.8%), from €30,888 to €35,766
- Financial charges -€1,785
down €1,785 (-22.7%), from €7,857 to €6,072
- Other operating charges +€1,287
up €1,287 (+14.2%), from €9,086 to €10,373
- Taxes +€1,115
new in 2025: €1,115
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,650,853 | €1,802,548 | +€151,696 | +9.2% |
| Fixed assets | 21/28 | €1,377,694 | €1,357,632 | -€20,062 | -1.5% |
| Tangible fixed assets | 22/27 | €634,456 | €614,394 | -€20,062 | -3.2% |
| Land and buildings | 22 | €634,456 | €614,394 | -€20,062 | -3.2% |
| Financial fixed assets | 28 | €743,238 | €743,238 | = | 0.0% |
| Current assets | 29/58 | €273,159 | €444,917 | +€171,758 | +62.9% |
| Amounts receivable within one year | 40/41 | €96,972 | €428,319 | +€331,347 | +342% |
| Other amounts receivable | 41 | €96,972 | €428,319 | +€331,347 | +342% |
| Cash at bank and in hand | 54/58 | €174,286 | €1,487 | -€172,799 | -99.1% |
| Deferred charges and accrued income | 490/1 | €1,900 | €15,110 | +€13,210 | +695% |
| Total equity and liabilities | 10/49 | €1,650,853 | €1,802,548 | +€151,696 | +9.2% |
| Equity | 10/15 | €1,060,444 | €1,071,597 | +€11,153 | +1.1% |
| Contributions | 10/11 | €600,000 | €600,000 | = | 0.0% |
| Reserves | 13 | €460,444 | €471,597 | +€11,153 | +2.4% |
| Tax-exempt reserves | 132 | €4,426 | €4,426 | = | 0.0% |
| Distributable reserves | 133 | €456,018 | €467,171 | +€11,153 | +2.4% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €590,409 | €730,952 | +€140,543 | +23.8% |
| Amounts payable after more than one year | 17 | €130,794 | €93,351 | -€37,443 | -28.6% |
| Financial debts | 170/4 | €130,794 | €93,351 | -€37,443 | -28.6% |
| Amounts payable within one year | 42/48 | €457,195 | €637,068 | +€179,873 | +39.3% |
| Current portion of amounts payable after more than one year | 42 | €35,991 | €37,443 | +€1,451 | +4.0% |
| Trade debts | 44 | €30 | €117 | +€87 | +291% |
| Suppliers | 440/4 | €30 | €117 | +€87 | +291% |
| Taxes, remuneration and social security | 45 | - | €1,115 | +€1,115 | |
| Taxes | 450/3 | - | €1,115 | +€1,115 | |
| Other amounts payable | 47/48 | €421,173 | €598,393 | +€177,219 | +42.1% |
| Accrued charges and deferred income | 492/3 | €2,420 | €532 | -€1,887 | -78.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €20,062 | €20,062 | +€0 | 0.0% |
| Other operating charges | 640/8 | €9,086 | €10,373 | +€1,287 | +14.2% |
| Gross operating margin | 9900 | €30,888 | €35,766 | +€4,878 | +15.8% |
| Operating profit (loss) | 9901 | €1,740 | €5,331 | +€3,591 | +206% |
| Financial income | 75/76B | €192 | €13,009 | +€12,818 | +6,691% |
| Recurring financial income | 75 | €192 | €13,009 | +€12,818 | +6,691% |
| Financial charges | 65/66B | €7,857 | €6,072 | -€1,785 | -22.7% |
| Recurring financial charges | 65 | €7,857 | €6,072 | -€1,785 | -22.7% |
| Profit (loss) for the period before taxes | 9903 | -€5,926 | €12,268 | +€18,194 | |
| Income taxes | 67/77 | - | €1,115 | +€1,115 | |
| Profit (loss) for the period | 9904 | -€5,926 | €11,153 | +€17,079 | |
| Profit (loss) for the period to be appropriated | 9905 | -€5,926 | €11,153 | +€17,079 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.